United States · 
What does Oxford Bioscience Partners invest in?
Oxford Bioscience Partners invests most often at Series B and Series C (57% of the rounds on record), in sectors such as Information Technology and Logistics.
Oxford Bioscience Partners highlights
- 01
73 rounds on record
- 02
Mostly Series B and Series C: 57% of its rounds
- 03
Sole investor in 1 rounds, median $2.0M
- 04
23 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Information TechnologyLogistics
- Based in
- United States
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first73 appearances
- 2014
1 round
- May
- 2013
2 rounds
- Sept
- Jul
- 2012
2 rounds
- May
- Jan
- 2011
1 round
- Feb
- 2010
5 rounds
- Sept
- Apr
- Mar
- Jan
- Jan
- 2009
8 rounds
- Nov
- Oct
- Jun
- May
- Mar
- Mar
- Mar
- Jan
- 2008
5 rounds
- Dec
- Nov
- Jul
- Mar
- Jan
- 2007
14 rounds
- Dec
- Nov
- Oct
- Oct
- Sept
- Aug
- May
- Apr
- Apr
- Apr
- Mar
- Mar
- Jan
- Jan
- 2006
4 rounds
- Dec
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed23 in all
Coherex MedicalBought by Biosense WebsterUndisclosedNov 2015
Seahorse BioscienceBought by Agilent Technologies$235MSept 2015
Affinium PharmaceuticalsBought by Debiopharm GroupUndisclosedFeb 2014
XencorListed$70MDec 2013
CircuLiteBought by HeartWare International$30MDec 2013
ACADIA PharmaceuticalsListed$115MMay 2013
Enanta PharmaceuticalsListed$56MMar 2013
SuperDimensionBought by Covidien$300MMar 2012
Claros DiagnosticsBought by OPKO HealthUndisclosedOct 2011
Pathway Medical TechnologiesBought by MEDRADUndisclosedSept 2011
ImpactRxBought by Symphony Technology GroupUndisclosedApr 2011
Intechra HoldingsBought by Arrow ElectronicsUndisclosedDec 2010
Solstice NeurosciencesBought by US WorldMeds$36MAug 2010
AVEO PharmaceuticalsListedUndisclosedMar 2010
BioProcessorsBought by Seahorse BioscienceUndisclosedMar 2009
FlowMedicaBought by AngioDynamicsUndisclosedJan 2009
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
Critical Therapeutics,Inc.Bought by Cornerstone TherapeuticsUndisclosedMay 2008
Alantos PharmaceuticalsBought by AmgenUndisclosedJun 2007
HypnionBought by LillyUndisclosedApr 2007
The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.